var data={"title":"Chronic obstructive pulmonary disease: Prognostic factors and comorbid conditions","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Chronic obstructive pulmonary disease: Prognostic factors and comorbid conditions</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/contributors\" class=\"contributor contributor_credentials\">Scott T Weiss, MD, MS</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/contributors\" class=\"contributor contributor_credentials\">James K Stoller, MD, MS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/contributors\" class=\"contributor contributor_credentials\">Helen Hollingsworth, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Apr 17, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A variety of clinical factors are thought to influence the natural history and prognosis of patients with chronic obstructive pulmonary disease (COPD) [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/1-3\" class=\"abstract_t\">1-3</a>]. These factors and the impact of acute exacerbations on disease outcome will be reviewed here.</p><p>The diagnosis and management of COPD are discussed elsewhere. (See <a href=\"topic.htm?path=chronic-obstructive-pulmonary-disease-definition-clinical-manifestations-diagnosis-and-staging\" class=\"medical medical_review\">&quot;Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging&quot;</a> and <a href=\"topic.htm?path=management-of-exacerbations-of-chronic-obstructive-pulmonary-disease\" class=\"medical medical_review\">&quot;Management of exacerbations of chronic obstructive pulmonary disease&quot;</a> and <a href=\"topic.htm?path=management-of-stable-chronic-obstructive-pulmonary-disease\" class=\"medical medical_review\">&quot;Management of stable chronic obstructive pulmonary disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">PROGNOSTIC FACTORS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of factors have been identified as prognostic indicators for COPD. In addition to the forced expiratory volume in one second (FEV<sub>1</sub>), other predictors of accelerated lung function decline, diminished physical function, <span class=\"nowrap\">and/or</span> mortality in patients with COPD include [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/4-14\" class=\"abstract_t\">4-14</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Airways responsiveness</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cigarette smoking</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Low body-mass index (BMI &le;21)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>HIV infection</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased airway bacterial load</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Decreased exercise capacity</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peak oxygen consumption (VO<sub>2</sub>), measured by cardiopulmonary exercise testing</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Elevated C-reactive protein (&gt;3 <span class=\"nowrap\">mg/L)</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Male gender</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chest computed tomography showing presence of emphysema</p><p/><p class=\"headingAnchor\" id=\"H20085935\"><span class=\"h2\">Forced expiratory volume in one second</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The FEV<sub>1</sub> is the parameter most commonly used to assess the course of COPD and to predict future changes in lung function and survival [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/15-18\" class=\"abstract_t\">15-18</a>]. The change in FEV<sub>1</sub> over time has been assessed in several studies and is affected by smoking status, but is also highly variable among individual patients [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/16,19,20\" class=\"abstract_t\">16,19,20</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a three-year study, the changes in the FEV<sub>1</sub> measured after administration of bronchodilator were assessed in 2163 subjects with COPD [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/16\" class=\"abstract_t\">16</a>]. The overall rate of decline was 33 mL per year, although almost 40 percent of the subjects had a decline of more than 40 mL per year. A high variability in the rate of decline in FEV<sub>1</sub> was noted, with higher rates in current smokers (54 mL per year), patients with bronchodilator reversibility, and patients with emphysema on computed tomography (CT).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the United States Lung Health Study, the rate of decline in post-bronchodilator FEV<sub>1</sub> was assessed in 5887 smokers with mild to moderate COPD [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/17\" class=\"abstract_t\">17</a>]. The unadjusted annual decline was 53.1 <span class=\"nowrap\">mL/year</span> at year 5 and 53.9 <span class=\"nowrap\">mL/year</span> by year 12, by which time 46 percent were still active smokers.</p><p/><p>The postbronchodilator FEV<sub>1</sub> has also been used to predict survival [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/15\" class=\"abstract_t\">15</a>]. Among 200 patients with COPD, who were followed for 15 years, after controlling for age, the postbronchodilator FEV<sub>1</sub> was the best predictor of survival (<a href=\"image.htm?imageKey=PULM%2F61524\" class=\"graphic graphic_table graphicRef61524 \">table 1</a>). However, a wide individual variability in prognosis was noted.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">BODE index</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A multidimensional index (the BODE index) was developed to assess an individual's risk of death from COPD. The four factors included in the index are weight (BMI), airway obstruction (FEV<sub>1</sub>), dyspnea (Medical Research Council dyspnea score), and exercise capacity (six-minute walk distance) (<a href=\"topic.htm?path=calculator-bode-index-for-copd-survival-prediction-in-adults\" class=\"calc calc_professional\">calculator 1</a>). The BODE index is superior to unidimensional assessment based on the FEV<sub>1</sub> value alone [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/4,12\" class=\"abstract_t\">4,12</a>]. The utility of the BODE index is not confined to assessing the risk of death; it can also predict hospitalization [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/21\" class=\"abstract_t\">21</a>].</p><p>The majority of patients with COPD have a stable BODE index over time, as demonstrated in a longitudinal study of 751 patients who were followed for a median of 64 months [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/19\" class=\"abstract_t\">19</a>]. A statistically significant increase in the BODE index was noted in 14 percent; these patients had more severe obstruction at baseline than those with a stable BODE index.</p><p>A modified BODE (mBODE) index uses an alternate dyspnea questionnaire (ie, UCSD SOBQ) and is a better predictor of mortality than its separate components [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/22\" class=\"abstract_t\">22</a>]. (See <a href=\"topic.htm?path=chronic-obstructive-pulmonary-disease-definition-clinical-manifestations-diagnosis-and-staging#H15\" class=\"medical medical_review\">&quot;Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging&quot;, section on 'Staging'</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Body mass</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Body mass index (BMI) is an independent risk factor in COPD. Decreasing body mass is associated with increasing mortality [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/23-25\" class=\"abstract_t\">23-25</a>]. Further weight loss increases mortality risk, whereas weight gain improves prognosis [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/26,27\" class=\"abstract_t\">26,27</a>].</p><p>The fat-free mass index (FFMI) provides information beyond that provided by the BMI.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The FFMI can identify a subgroup of patients with an increased mortality risk despite a normal BMI. This was illustrated by a prospective cohort study of 1898 patients with COPD who were followed for a mean of seven years [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/28\" class=\"abstract_t\">28</a>]. Both BMI and FFMI were predictors of mortality. Among patients with a normal BMI, FFMI was a predictor of mortality (26 percent had an FFMI lower than the tenth percentile).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The FFMI is a better predictor of disease severity. While both BMI and FFMI correlate with the six-minute walk test, only FFMI correlates with the degree of chronic dyspnea, the FEV<sub>1</sub>, the FEV<sub>1</sub><span class=\"nowrap\">/forced</span> vital capacity (FVC) ratio, or the stage of disease, according to one observational study [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/29\" class=\"abstract_t\">29</a>].</p><p/><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Bronchodilator response</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Histamine-induced airway hyperresponsiveness is a predictor of mortality [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/6\" class=\"abstract_t\">6</a>]. Conversely, it is uncertain whether bronchodilation due to a beta-agonist predicts mortality.</p><p class=\"headingAnchor\" id=\"H200428268\"><span class=\"h2\">Types of COPD</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Only a few studies have focused on prognosis of specific types of COPD. In one study of 609 patients with severe emphysema (mean FEV<sub>1</sub> 27 percent of predicted), the following factors predicted mortality: advanced age (&ge;70 years), supplemental oxygen use, total lung capacity (&lt;140 percent of predicted), residual volume (&ge;262 percent of predicted), maximal workload during cardiopulmonary exercise testing (&le;25 W for females, &le;40 W for males), BODE index (&ge;7), and increased emphysema <span class=\"nowrap\">and/or</span> blood flow to the lower lung zones [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/30\" class=\"abstract_t\">30</a>]. (See <a href=\"topic.htm?path=chronic-obstructive-pulmonary-disease-definition-clinical-manifestations-diagnosis-and-staging#H2\" class=\"medical medical_review\">&quot;Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging&quot;, section on 'Definitions'</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Acute exacerbations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with COPD are frequently hospitalized for acute exacerbations, most commonly in association with respiratory infections. The effect of these exacerbations on survival is unclear, with estimates varying widely [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/31-38\" class=\"abstract_t\">31-38</a>].</p><p>In a study of 1016 patients hospitalized with COPD exacerbation complicated by hypercapnia (PaCO<sub>2</sub> &gt;50 mmHg at admission), the in-hospital, 60-day, 90-day, one-year, and two-year mortality rate was 11, 20, 33, 43, and 49 percent, respectively [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/33\" class=\"abstract_t\">33</a>]. Patient characteristics associated with death at six months included:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic health status</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nutritional status</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Coexisting cardiac disease</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Severity of the acute illness (determined by the Acute Physiologic And Chronic Health Evaluation [APACHE] score and the PaO<sub>2</sub><span class=\"nowrap\">/FiO<sub>2</sub></span> ratio)</p><p/><p>Interestingly, the presence of heart failure or cor pulmonale was associated with a longer survival time after adjustment for other variables. This may be the result of the relatively good response of these disorders to acute therapy.</p><p>Subsequent studies have identified additional factors associated with poor outcome due to COPD exacerbation. Decreased levels of serum albumin [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/31\" class=\"abstract_t\">31</a>], low BMI [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/31\" class=\"abstract_t\">31</a>], advanced pulmonary disease [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/37\" class=\"abstract_t\">37</a>], and nonrespiratory organ dysfunction [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/37\" class=\"abstract_t\">37</a>] are predictive of long-term mortality. In contrast, advanced age [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/37\" class=\"abstract_t\">37</a>], prolonged hospital length of stay before ICU admission [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/37\" class=\"abstract_t\">37</a>], severe respiratory dysfunction [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/37,38\" class=\"abstract_t\">37,38</a>], and severe nonrespiratory organ dysfunction are associated with in-hospital mortality [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/37,38\" class=\"abstract_t\">37,38</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Hypercapnia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypercapnia induced by an acute exacerbation of COPD does not predict increased mortality compared to eucapnia. In a five-year observational study of 85 patients admitted to the hospital with a COPD exacerbation, survival was similar among eucapnic patients (33 percent) and acutely hypercapnic patients (28 percent) [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/34\" class=\"abstract_t\">34</a>]. In contrast, patients with chronic hypercapnia had a decreased five-year survival (11 percent) (<a href=\"image.htm?imageKey=PULM%2F58903\" class=\"graphic graphic_figure graphicRef58903 \">figure 1</a>). All three groups had similar levels of pulmonary function, as measured by FEV<sub>1</sub> and FVC. Only 24 percent of the patients who became hypercapnic during the acute illness subsequently developed chronic hypercapnia.</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Acute respiratory failure</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute respiratory failure due to a COPD exacerbation does not appear to be associated with diminished long-term survival [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/35,37\" class=\"abstract_t\">35,37</a>]. In an observational study of 36 patients with acute respiratory failure due to an acute exacerbation of COPD, two-year survival was 72 percent [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/35\" class=\"abstract_t\">35</a>]. Compared to controls with similar baseline pulmonary function, there was no difference in two-year mortality.</p><p>A common clinical question is whether recurrent episodes of acute respiratory failure and mechanical ventilation affect the prognosis of COPD. Unfortunately, little data exists to answer this question.</p><p>A retrospective cohort study of 74 patients with severe COPD (mean FEV<sub>1</sub> 0.74 L) complicated by acute respiratory failure and ICU admission found an in-hospital mortality of 20 percent [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/38\" class=\"abstract_t\">38</a>]. In this population, the cumulative mortality at one, two, and three years was 48, 58, and 64 percent, respectively. The degree of hypercarbia and higher APACHE II scores were correlated with in-hospital mortality; however, clinical factors independently associated with long-term survival could not be identified.</p><p class=\"headingAnchor\" id=\"H1308082290\"><span class=\"h2\">C-reactive protein</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>C-reactive protein (CRP) is an acute phase reactant that is a sensitive, but not specific predictor of inflammation. An elevated CRP has been associated with increased morbidity and mortality and declining pulmonary function in some studies of patients with COPD [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/10,39\" class=\"abstract_t\">10,39</a>], but not others [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/40,41\" class=\"abstract_t\">40,41</a>]. (See <a href=\"topic.htm?path=acute-phase-reactants#H11\" class=\"medical medical_review\">&quot;Acute phase reactants&quot;, section on 'C-reactive protein'</a>.)</p><p>In the European Prospective Investigation Into Cancer (EPIC)-Norfolk study, high-sensitivity CRP levels and spirometry were assessed in 18,110 participants at baseline, 4 years (spirometry only), and 13 years [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/39\" class=\"abstract_t\">39</a>]. An elevated baseline CRP was associated with lower baseline FEV<sub>1</sub> and FVC. In addition, an increase in CRP over time correlated with a slightly greater rate of decline in FEV<sub>1</sub> and FVC multivariate analysis. However, the baseline CRP level was not predictive of the annual rate of change in FEV<sub>1</sub> or FVC. </p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">COMORBID DISEASES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>COPD has been linked to comorbid conditions such as cardiovascular diseases (eg, hypertension, coronary heart disease, stroke) [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/42-47\" class=\"abstract_t\">42-47</a>], diabetes mellitus [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/48,49\" class=\"abstract_t\">48,49</a>], renal insufficiency [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/50\" class=\"abstract_t\">50</a>], osteoporosis [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/51,52\" class=\"abstract_t\">51,52</a>], psychiatric illness (eg, depression and anxiety) [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/53-61\" class=\"abstract_t\">53-61</a>], and cognitive dysfunction [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/62-65\" class=\"abstract_t\">62-65</a>]. (See <a href=\"topic.htm?path=overview-of-established-risk-factors-for-cardiovascular-disease#H4872547\" class=\"medical medical_review\">&quot;Overview of established risk factors for cardiovascular disease&quot;, section on 'Cigarette smoking'</a> and <a href=\"topic.htm?path=osteoporotic-fracture-risk-assessment#H23\" class=\"medical medical_review\">&quot;Osteoporotic fracture risk assessment&quot;, section on 'Cigarette smoking'</a> and <a href=\"topic.htm?path=overview-of-the-management-of-osteoporosis-in-postmenopausal-women\" class=\"medical medical_review\">&quot;Overview of the management of osteoporosis in postmenopausal women&quot;</a> and <a href=\"topic.htm?path=treatment-of-osteoporosis-in-men\" class=\"medical medical_review\">&quot;Treatment of osteoporosis in men&quot;</a>.)</p><p>A potential association between COPD and renal insufficiency was evaluated in a series of 356 older adults (mean age 75.4 years) with COPD [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/50\" class=\"abstract_t\">50</a>]. Renal insufficiency (glomerular filtration rate [GFR] &lt;60 <span class=\"nowrap\">mL/min/1</span>.73 m2) was detected in 43 percent, compared with 23 percent of older adults without COPD. In addition, approximately half of the patients with COPD and a reduced GFR had a normal serum creatinine. This latter group of patients with &quot;covert&quot; renal insufficiency was more likely to have a low serum albumin and low muscle mass.</p><p>A three-year observational study, the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study, examined the prevalence of depression among 2118 subjects with COPD, 335 smokers without COPD, and 243 nonsmokers [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/58\" class=\"abstract_t\">58</a>]. Depression was more prevalent among subjects with COPD (26 percent), than smokers without COPD (12 percent) or nonsmokers (7 percent) and was associated with worse health and functional status. Additional studies are needed to determine the optimal methods for the diagnosis [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/59,60\" class=\"abstract_t\">59,60</a>] and treatment of depression in patients with COPD, although comprehensive pulmonary rehabilitation programs appear helpful. (See <a href=\"topic.htm?path=pulmonary-rehabilitation#H16\" class=\"medical medical_review\">&quot;Pulmonary rehabilitation&quot;, section on 'Psychological support'</a> and <a href=\"topic.htm?path=unipolar-major-depression-in-adults-choosing-initial-treatment\" class=\"medical medical_review\">&quot;Unipolar major depression in adults: Choosing initial treatment&quot;</a> and <a href=\"topic.htm?path=unipolar-depression-in-adults-supportive-psychotherapy\" class=\"medical medical_review\">&quot;Unipolar depression in adults: Supportive psychotherapy&quot;</a> and <a href=\"topic.htm?path=screening-for-depression-in-adults\" class=\"medical medical_review\">&quot;Screening for depression in adults&quot;</a>.)</p><p>Cognition impairment was evaluated in a survey of 4150 older adults [<a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/62\" class=\"abstract_t\">62</a>]. The adjusted mean cognition scores of those with severe COPD were significantly lower than those with nonsevere or absent COPD. (See <a href=\"topic.htm?path=mild-cognitive-impairment-epidemiology-pathology-and-clinical-assessment\" class=\"medical medical_review\">&quot;Mild cognitive impairment: Epidemiology, pathology, and clinical assessment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.) </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=chronic-obstructive-pulmonary-disease-copd-including-emphysema-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Beyond the Basics topics (see <a href=\"topic.htm?path=chronic-obstructive-pulmonary-disease-copd-including-emphysema-beyond-the-basics\" class=\"medical medical_patient\">&quot;Patient education: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The natural history and prognosis of COPD are variable and factors influencing this variability are incompletely understood. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A number of factors, such as genetic predisposition, severity of disease, environmental exposures, comorbidities, and, to a lesser degree, acute exacerbations, appear to influence prognosis. (See <a href=\"#H2\" class=\"local\">'Prognostic factors'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Short-term (ie, in-hospital) survival for patients with COPD and respiratory failure is determined by the overall severity of acute illness, rather than the degree of respiratory failure. In comparison, long-term survival is primarily influenced by the severity of COPD and the presence of comorbid conditions. (See <a href=\"#H6\" class=\"local\">'Acute exacerbations'</a> above and <a href=\"#H8\" class=\"local\">'Acute respiratory failure'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>COPD is associated with a number of comorbid conditions, such as cardiovascular diseases (eg, hypertension, coronary heart disease, stroke), diabetes mellitus, renal insufficiency, osteoporosis, psychiatric illness (eg, depression and anxiety), and cognitive dysfunction. (See <a href=\"#H9\" class=\"local\">'Comorbid diseases'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/1\" class=\"nounderline abstract_t\">Dolan S, Varkey B. Prognostic factors in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2005; 11:149.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/2\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Deaths from chronic obstructive pulmonary disease--United States, 2000-2005. MMWR Morb Mortal Wkly Rep 2008; 57:1229.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/3\" class=\"nounderline abstract_t\">Ford ES. Trends in mortality from COPD among adults in the United States. Chest 2015; 148:962.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/4\" class=\"nounderline abstract_t\">Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:1005.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/5\" class=\"nounderline abstract_t\">Heffner JE, Mularski RA, Calverley PM. COPD performance measures: missing opportunities for improving care. Chest 2010; 137:1181.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/6\" class=\"nounderline abstract_t\">Hospers JJ, Postma DS, Rijcken B, et al. Histamine airway hyper-responsiveness and mortality from chronic obstructive pulmonary disease: a cohort study. Lancet 2000; 356:1313.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/7\" class=\"nounderline abstract_t\">Diaz PT, King MA, Pacht ER, et al. Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Ann Intern Med 2000; 132:369.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/8\" class=\"nounderline abstract_t\">Wilkinson TM, Patel IS, Wilks M, et al. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167:1090.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/9\" class=\"nounderline abstract_t\">Berry MJ, Adair NE, Rejeski WJ. Use of peak oxygen consumption in predicting physical function and quality of life in COPD patients. Chest 2006; 129:1516.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/10\" class=\"nounderline abstract_t\">Dahl M, Vestbo J, Lange P, et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:250.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/11\" class=\"nounderline abstract_t\">Drummond MB, Blackford AL, Benditt JO, et al. Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial. Chest 2008; 134:497.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/12\" class=\"nounderline abstract_t\">de Torres JP, Cote CG, L&oacute;pez MV, et al. Sex differences in mortality in patients with COPD. Eur Respir J 2009; 33:528.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/13\" class=\"nounderline abstract_t\">Kohansal R, Martinez-Camblor P, Agust&iacute; A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009; 180:3.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/14\" class=\"nounderline abstract_t\">Haruna A, Muro S, Nakano Y, et al. CT scan findings of emphysema predict mortality in COPD. Chest 2010; 138:635.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/15\" class=\"nounderline abstract_t\">Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease. A 15-year follow-up study. Am Rev Respir Dis 1979; 119:895.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/16\" class=\"nounderline abstract_t\">Vestbo J, Edwards LD, Scanlon PD, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 2011; 365:1184.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/17\" class=\"nounderline abstract_t\">Drummond MB, Hansel NN, Connett JE, et al. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185:1301.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/18\" class=\"nounderline abstract_t\">Miniati M, Monti S, Pavlickova I, Bottai M. Survival in COPD: impact of lung dysfunction and comorbidities. Medicine (Baltimore) 2014; 93:e76.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/19\" class=\"nounderline abstract_t\">Casanova C, de Torres JP, Aguirre-Ja&iacute;me A, et al. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med 2011; 184:1015.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/20\" class=\"nounderline abstract_t\">Nishimura M, Makita H, Nagai K, et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185:44.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/21\" class=\"nounderline abstract_t\">Ong KC, Earnest A, Lu SJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005; 128:3810.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/22\" class=\"nounderline abstract_t\">Martinez FJ, Han MK, Andrei AC, et al. Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med 2008; 178:491.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/23\" class=\"nounderline abstract_t\">Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis 1989; 139:1435.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/24\" class=\"nounderline abstract_t\">Gray-Donald K, Gibbons L, Shapiro SH, et al. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153:961.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/25\" class=\"nounderline abstract_t\">Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1791.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/26\" class=\"nounderline abstract_t\">Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:1856.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/27\" class=\"nounderline abstract_t\">Prescott E, Almdal T, Mikkelsen KL, et al. Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study. Eur Respir J 2002; 20:539.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/28\" class=\"nounderline abstract_t\">Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173:79.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/29\" class=\"nounderline abstract_t\">Ischaki E, Papatheodorou G, Gaki E, et al. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest 2007; 132:164.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/30\" class=\"nounderline abstract_t\">Martinez FJ, Foster G, Curtis JL, et al. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 2006; 173:1326.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/31\" class=\"nounderline abstract_t\">Gunen H, Hacievliyagil SS, Kosar F, et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J 2005; 26:234.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/32\" class=\"nounderline abstract_t\">Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003; 163:1180.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/33\" class=\"nounderline abstract_t\">Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996; 154:959.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/34\" class=\"nounderline abstract_t\">Costello R, Deegan P, Fitzpatrick M, McNicholas WT. Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med 1997; 102:239.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/35\" class=\"nounderline abstract_t\">Martin TR, Lewis SW, Albert RK. The prognosis of patients with chronic obstructive pulmonary disease after hospitalization for acute respiratory failure. Chest 1982; 82:310.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/36\" class=\"nounderline abstract_t\">Hudson LD. Survival data in patients with acute and chronic lung disease requiring mechanical ventilation. Am Rev Respir Dis 1989; 140:S19.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/37\" class=\"nounderline abstract_t\">Seneff MG, Wagner DP, Wagner RP, et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274:1852.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/38\" class=\"nounderline abstract_t\">Breen D, Churches T, Hawker F, Torzillo PJ. Acute respiratory failure secondary to chronic obstructive pulmonary disease treated in the intensive care unit: a long term follow up study. Thorax 2002; 57:29.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/39\" class=\"nounderline abstract_t\">Ahmadi-Abhari S, Kaptoge S, Luben RN, et al. Longitudinal association of C-reactive protein and lung function over 13 years: The EPIC-Norfolk study. Am J Epidemiol 2014; 179:48.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/40\" class=\"nounderline abstract_t\">de Torres JP, Pinto-Plata V, Casanova C, et al. C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008; 133:1336.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/41\" class=\"nounderline abstract_t\">Stolz D, Christ-Crain M, Morgenthaler NG, et al. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD. Chest 2007; 131:1058.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/42\" class=\"nounderline abstract_t\">Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2:8.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/43\" class=\"nounderline abstract_t\">Barr RG, Bluemke DA, Ahmed FS, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010; 362:217.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/44\" class=\"nounderline abstract_t\">Watz H, Waschki B, Meyer T, et al. Decreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation. Chest 2010; 138:32.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/45\" class=\"nounderline abstract_t\">Williams MC, Murchison JT, Edwards LD, et al. Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortality. Thorax 2014; 69:718.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/46\" class=\"nounderline abstract_t\">Portegies ML, Lahousse L, Joos GF, et al. Chronic Obstructive Pulmonary Disease and the Risk of Stroke. The Rotterdam Study. Am J Respir Crit Care Med 2016; 193:251.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/47\" class=\"nounderline abstract_t\">Takagi H, Umemoto T, ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. A Meta-Analysis of the Association of Chronic Obstructive Pulmonary Disease with Abdominal Aortic Aneurysm Presence. Ann Vasc Surg 2016; 34:84.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/48\" class=\"nounderline abstract_t\">Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010; 65:956.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/49\" class=\"nounderline abstract_t\">Meteran H, Backer V, Kyvik KO, et al. Comorbidity between chronic obstructive pulmonary disease and type 2 diabetes: A nation-wide cohort twin study. Respir Med 2015; 109:1026.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/50\" class=\"nounderline abstract_t\">Incalzi RA, Corsonello A, Pedone C, et al. Chronic renal failure: a neglected comorbidity of COPD. Chest 2010; 137:831.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/51\" class=\"nounderline abstract_t\">Ferguson GT, Calverley PMA, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest 2009; 136:1456.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/52\" class=\"nounderline abstract_t\">Bon J, Fuhrman CR, Weissfeld JL, et al. Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med 2011; 183:885.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/53\" class=\"nounderline abstract_t\">Light RW, Merrill EJ, Despars JA, et al. Prevalence of depression and anxiety in patients with COPD. Relationship to functional capacity. Chest 1985; 87:35.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/54\" class=\"nounderline abstract_t\">Omachi TA, Katz PP, Yelin EH, et al. Depression and health-related quality of life in chronic obstructive pulmonary disease. Am J Med 2009; 122:778.e9.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/55\" class=\"nounderline abstract_t\">Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest 2010; 137:341.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/56\" class=\"nounderline abstract_t\">Katz PP, Julian LJ, Omachi TA, et al. The impact of disability on depression among individuals with COPD. Chest 2010; 137:838.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/57\" class=\"nounderline abstract_t\">Kim KU, Park HK, Jung HY, et al. Association of depression with disease severity in patients with chronic obstructive pulmonary disease. Lung 2014; 192:243.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/58\" class=\"nounderline abstract_t\">Hanania NA, M&uuml;llerova H, Locantore NW, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med 2011; 183:604.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/59\" class=\"nounderline abstract_t\">Arimura Y, Yamazaki S, Yanagi S, et al. Clinical usefulness of the two-question assessment tool for depressive symptoms in Japanese patients with chronic obstructive pulmonary disease. Lung 2013; 191:101.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/60\" class=\"nounderline abstract_t\">Julian LJ, Gregorich SE, Earnest G, et al. Screening for depression in chronic obstructive pulmonary disease. COPD 2009; 6:452.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/61\" class=\"nounderline abstract_t\">Montserrat-Capdevila J, Godoy P, Marsal JR, et al. Overview of the Impact of Depression and Anxiety in Chronic Obstructive Pulmonary Disease. Lung 2017; 195:77.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/62\" class=\"nounderline abstract_t\">Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive decline among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180:134.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/63\" class=\"nounderline abstract_t\">Singh B, Parsaik AK, Mielke MM, et al. Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging. Mayo Clin Proc 2013; 88:1222.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/64\" class=\"nounderline abstract_t\">Singh B, Mielke MM, Parsaik AK, et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol 2014; 71:581.</a></li><li><a href=\"https://www.uptodate.com/contents/chronic-obstructive-pulmonary-disease-prognostic-factors-and-comorbid-conditions/abstract/65\" class=\"nounderline abstract_t\">Martinez CH, Richardson CR, Han MK, Cigolle CT. Chronic obstructive pulmonary disease, cognitive impairment, and development of disability: the health and retirement study. Ann Am Thorac Soc 2014; 11:1362.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1439 Version 31.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H11\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">PROGNOSTIC FACTORS</a><ul><li><a href=\"#H20085935\" id=\"outline-link-H20085935\">Forced expiratory volume in one second</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">BODE index</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Body mass</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Bronchodilator response</a></li><li><a href=\"#H200428268\" id=\"outline-link-H200428268\">Types of COPD</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Acute exacerbations</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Hypercapnia</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Acute respiratory failure</a></li><li><a href=\"#H1308082290\" id=\"outline-link-H1308082290\">C-reactive protein</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">COMORBID DISEASES</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H10\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PULM/1439|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/58903\" class=\"graphic graphic_figure\">- Kaplan Meier curves in COPD</a></li></ul></li><li><div id=\"PULM/1439|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/61524\" class=\"graphic graphic_table\">- FEV1 and survival in COPD</a></li></ul></li></ul></div></div><div><h2>CALCULATORS</h2><div id=\"outlineCalculators\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=calculator-bode-index-for-copd-survival-prediction-in-adults\" title=\"calculator 1\" class=\"calc calc_professional\">Calculator: BODE Index for COPD survival prediction in adults</a></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-phase-reactants\" class=\"medical medical_review\">Acute phase reactants</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-obstructive-pulmonary-disease-definition-clinical-manifestations-diagnosis-and-staging\" class=\"medical medical_review\">Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-exacerbations-of-chronic-obstructive-pulmonary-disease\" class=\"medical medical_review\">Management of exacerbations of chronic obstructive pulmonary disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-stable-chronic-obstructive-pulmonary-disease\" class=\"medical medical_review\">Management of stable chronic obstructive pulmonary disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mild-cognitive-impairment-epidemiology-pathology-and-clinical-assessment\" class=\"medical medical_review\">Mild cognitive impairment: Epidemiology, pathology, and clinical assessment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=osteoporotic-fracture-risk-assessment\" class=\"medical medical_review\">Osteoporotic fracture risk assessment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-established-risk-factors-for-cardiovascular-disease\" class=\"medical medical_review\">Overview of established risk factors for cardiovascular disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-management-of-osteoporosis-in-postmenopausal-women\" class=\"medical medical_review\">Overview of the management of osteoporosis in postmenopausal women</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-obstructive-pulmonary-disease-copd-including-emphysema-beyond-the-basics\" class=\"medical medical_patient\">Patient education: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-obstructive-pulmonary-disease-copd-including-emphysema-the-basics\" class=\"medical medical_basics\">Patient education: Chronic obstructive pulmonary disease (COPD), including emphysema (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pulmonary-rehabilitation\" class=\"medical medical_review\">Pulmonary rehabilitation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-depression-in-adults\" class=\"medical medical_review\">Screening for depression in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-osteoporosis-in-men\" class=\"medical medical_review\">Treatment of osteoporosis in men</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=unipolar-depression-in-adults-supportive-psychotherapy\" class=\"medical medical_review\">Unipolar depression in adults: Supportive psychotherapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=unipolar-major-depression-in-adults-choosing-initial-treatment\" class=\"medical medical_review\">Unipolar major depression in adults: Choosing initial treatment</a></li></ul></div></div>","javascript":null}